Perspectives of Diabetes Mellitus on Vital Organ

International Journal of Medical Science

© 2024 by SSRG - IJMS Journal

Volume 11 Issue 4

Year of Publication : 2024

Authors : Sandhya Pandey, Divya Mishra, Dev Brat Mishra, Sheela Yadav, Prashant Singh

10.14445/23939117/IJMS-V11I4P104

How to Cite?

Sandhya Pandey, Divya Mishra, Dev Brat Mishra, Sheela Yadav, Prashant Singh, "Perspectives of Diabetes Mellitus on Vital Organ," SSRG International Journal of Medical Science, vol. 11,  no. 4, pp. 25-28, 2024. Crossref, https://doi.org/10.14445/23939117/IJMS-V11I4P104

Abstract:

The study investigates the association between type 2 diabetes mellitus and liver function in 50 diabetic individuals compared to 30 controls, predominantly males. Liver function tests, including ALT, AST, ALP, serum albumin, and bilirubin, were conducted. Diabetic individuals were categorized into four grades based on fasting blood sugar levels. Compared to controls, diabetic individuals exhibited lower levels of total serum proteins, albumin, and albumin to globulin ratio, with grade IV diabetes showing particularly notable deviations, including low total serum proteins and albumin levels, alongside elevated thymol turbidity and alkaline phosphatase. However, individuals with lower-grade diabetes did not display significant alterations in liver function. This study underscores the importance of monitoring liver function, especially in advanced stages of type 2 diabetes, for timely intervention and management.

Keywords:

Vital organ, Severity of diabetes, Liver function, Controlled diabetics, Uncontrolled diabetics.

References:

[1] Aditya Chilay et al., “Liver Function Test and Diabetes Mellitus: Correlation from a Laboratory Perspective,” Indian Journal of Medical Biochemistry, vol. 27, no. 2, pp. 40-44, 2023.
[CrossRef] [Google Scholar] [Publisher Link]
[2] Ayman S. Idris et al., “Liver Function Tests in Type 2 Sudanese Diabetic Patients,” International Journal of Nutrition and Metabolism, vol. 3, no. 2, pp. 17-21, 2011.
[CrossRef] [Google Scholar] [Publisher Link]
[3] Rohan Gupta et al., “Study of Liver Function Tests in Patients with Long Standing Type 2 Diabetes Mellitus in Comparison to Healthy Individuals,” Journal of Evaluation of Medical and Dental Science, vol. 10, no. 5, pp. 289-293, 2021.
[CrossRef] [Google Scholar] [Publisher Link]
[4] Jamaludin Mahamed et al., “Mechanisms of Diabetes-Induced Liver Damage: The Role of Oxidative Stress and Inflammation,” Sultan Qaboos University Medical Journal, vol. 16, no. 2, pp. 132-141, 2016.
[CrossRef] [Google Scholar] [Publisher Link]
[5] Keith G. Tolman et al., “Spectrum of Liver Disease in Type 2 Diabetes and Management of Patients With Diabetes and Liver Disease,” Diabetes Care, vol. 30, no. 3, pp. 734-743, 2007.
[CrossRef] [Google Scholar] [Publisher Link]
[6] Ajita Acharya et al., “Diabetes and Liver an Association: Hepatogenous Diabetes Mechanism and Some Evidences,” Journal of Cell Science & Therapy, vol. 7, no. 6, pp. 1-6, 2016.
[Google Scholar] [Publisher Link]
[7] Gérard Siest et al., “Aspartate Aminotransferase and Alanine Aminotransferase Activities in Plasma: Statistical Distributions, Individual Variations, and Reference Values,” Clinical Chemistry, vol. 21, no. 8, pp. 1077-1087, 1975.
[CrossRef] [Google Scholar] [Publisher Link]
[8] Kaustubh Bora et al., “Presence of Concurrent Derangements of Liver Function Tests in Type 2 Diabetes and Their Relationship with Glycemic Status: A Retrospective Observational Study from Meghalaya,” Journal of Laboratory Physicians, vol. 8, no. 1, pp. 30-35, 2016.
[CrossRef] [Google Scholar] [Publisher Link]
[9] Hajime Yamazaki et al., “Independent Association Between Improvement of Nonalcoholic Fatty Liver Disease and Reduced Incidence of Type 2 Diabetes,” Diabetes Care, vol. 38, no. 9, pp. 1673-1679, 2015.
[CrossRef] [Google Scholar] [Publisher Link]
[10] Ki-Chul Sung et al., “Combined Influence of Insulin Resistance, Overweight/Obesity, and Fatty Liver as Risk Factors for Type 2 Diabetes,” Diabetes Care, vol. 35, no. 4, pp. 717-722, 2012.
[CrossRef] [Google Scholar] [Publisher Link]
[11] Ki-Chul Sung, Sarah H. Wild, and Christopher D. Byrne, “Resolution of Fatty Liver and Risk of Incident Diabetes,” Journal of Clinical Endocrinology & Metabolism, vol. 98, no. 9, pp. 3637-3643, 2013.
[CrossRef] [Google Scholar] [Publisher Link]
[12] Michihiko Shibata et al., “Nonalcoholic Fatty Liver Disease Is a Risk Factor for Type 2 Diabetes in Middle-Aged Japanese Men,” Diabetes Care, vol. 30, no. 11, pp. 2940-2944, 2007.
[CrossRef] [Google Scholar] [Publisher Link]
[13] Wei-Dong Li et al., “Comparison of Effects of Obesity and Non-Alcoholic Fatty Liver Disease on Incidence of Type 2 Diabetes Mellitus,” World Journal of Gastroenterology, vol. 21, no. 32, pp. 9607-9613, 2015.
[CrossRef] [Google Scholar] [Publisher Link]
[14] C.-H. Kim et al., “Fatty Liver is an Independent Risk Factor for the Development of Type 2 Diabetes in Korean Adults,” Diabetic Medicine, vol. 25, no. 4, pp. 476-481, 2008.
[CrossRef] [Google Scholar] [Publisher Link]
[15] Anuradhani Kasturiratne et al., “Influence of Non-Alcoholic Fatty Liver Disease on the Development of Diabetes Mellitus,” Journal of Gastroenterology and Hepatology, vol. 28, no. 1, pp. 142-147, 2013.
[CrossRef] [Google Scholar] [Publisher Link]
[16] Sasiwarang Goya Wannamethee et al., “Hepatic Enzymes, the Metabolic Syndrome, and the Risk of Type 2 Diabetes in Older Men,” Diabetes Care, vol. 28, no. 12, pp. 2913-2918, 2005.
[CrossRef] [Google Scholar] [Publisher Link]